84 related articles for article (PubMed ID: 36899319)
21. Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study.
Jiaao L; Wanli G; Kai Z; Feng G; Yunpeng P
Eur J Med Res; 2023 Oct; 28(1):436. PubMed ID: 37848965
[TBL] [Abstract][Full Text] [Related]
22. The Relationship of Neutrophil-to-Lymphocyte Ratio or Platelet-to-Lymphocyte Ratio and Pancreatic Cancer in Patients with Type 2 Diabetes.
Qin S; Lu Y; Chen S; Hu Z; Chen H; Zhong J; Li S; Chen Z
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307172
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection.
Wang SB; Chen JY; Xu C; Cao WG; Cai R; Cao L; Cai G
Front Oncol; 2022; 12():1040495. PubMed ID: 36387250
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory Cytokine: An Attractive Target for Cancer Treatment.
Lee HM; Lee HJ; Chang JE
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140220
[TBL] [Abstract][Full Text] [Related]
25. Nutritional risk screening in malignant tumors: a study of 375 cancer inpatients.
Zhang M; Guo Y; Zhang X; Zhang Y; Fan Y; Liu Y; Zhao K; Fan R; Lu P
Support Care Cancer; 2022 Oct; 30(10):8333-8337. PubMed ID: 35864360
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer.
Wang R; Zhao Y; Wang Y; Zhao Z; Chen Q; Duan Y; Xiong S; Luan Z; Wang J; Cheng B
Clin Transl Gastroenterol; 2022 May; 13(5):e00487. PubMed ID: 35351843
[TBL] [Abstract][Full Text] [Related]
27. Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer.
Wang L; Wu J; Ye N; Li F; Zhan H; Chen S; Xu J
Front Oncol; 2021; 11():739111. PubMed ID: 34589435
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment Nutrition-Inflammation Biomarkers Correlated with Differential Cytokine Profiles in Taiwanese Patients with Colorectal Cancer.
Yu YL; Tseng WK; Fan CW; Chang PH; Kuo HC; Pan YP; Yeh KY
Nutr Cancer; 2022; 74(5):1614-1624. PubMed ID: 34323132
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of Preoperative Fibrinogen-to-Prealbumin Ratio in Patients with Stage I-III Colorectal Cancer Undergoing Surgical Resection: A Retrospective Cohort Study.
Hailun Xie ; Huang S; Yuan G; Tang S; Gan J
Biomed Res Int; 2021; 2021():3905353. PubMed ID: 33521127
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
Zhang LP; Ren H; Du YX; Wang CF
World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
[TBL] [Abstract][Full Text] [Related]
31. Single and Combined Use of Preoperative Inflammatory Biomarkers and CA199 in Diagnosing Pancreatic Cancer.
Lu Y; Yu H; Qin S; Chen M; Chen H; Hu Z; Li S; Qin X
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180425
[TBL] [Abstract][Full Text] [Related]
32. Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer.
Fang L; Yan FH; Liu C; Chen J; Wang D; Zhang CH; Lou CJ; Lian J; Yao Y; Wang BJ; Li RY; Han SL; Bai YB; Yang JN; Li ZW; Zhang YQ
Cancer Res Treat; 2021 Jan; 53(1):131-139. PubMed ID: 32854494
[TBL] [Abstract][Full Text] [Related]
33. Emerging roles for the IL-6 family of cytokines in pancreatic cancer.
van Duijneveldt G; Griffin MDW; Putoczki TL
Clin Sci (Lond); 2020 Aug; 134(16):2091-2115. PubMed ID: 32808663
[TBL] [Abstract][Full Text] [Related]
34. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
[TBL] [Abstract][Full Text] [Related]
35. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters.
Park JW; Chang HJ; Yeo HY; Han N; Kim BC; Kong SY; Kim J; Oh JH
Br J Cancer; 2020 Aug; 123(4):610-618. PubMed ID: 32488137
[TBL] [Abstract][Full Text] [Related]
36. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis.
Sun DW; An L; Lv GY
World J Surg Oncol; 2020 Jan; 18(1):9. PubMed ID: 31931816
[TBL] [Abstract][Full Text] [Related]
37. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.
Das S; Shapiro B; Vucic EA; Vogt S; Bar-Sagi D
Cancer Res; 2020 Mar; 80(5):1088-1101. PubMed ID: 31915130
[TBL] [Abstract][Full Text] [Related]
38. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer.
Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
[TBL] [Abstract][Full Text] [Related]
39. Cellular determinants and therapeutic implications of inflammation in pancreatic cancer.
Stone ML; Beatty GL
Pharmacol Ther; 2019 Sep; 201():202-213. PubMed ID: 31158393
[TBL] [Abstract][Full Text] [Related]
40. Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study.
Wang Q; Tu H; Zhu M; Liang D; Ye Y; Chang DW; Long Y; Wu X
Carcinogenesis; 2019 Oct; 40(10):1191-1197. PubMed ID: 31001636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
